Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Clinical trial NCT02650401 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02650401
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-03
- Primary completion
- 2026-06-30
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.